The independent source for health policy research, polling, and news.
15,881 - 15,900 of 112,590 Results
In other news, research says that post-vaccine covid infection risks are very low in medical workers; Oregon's mixup will allow 11,000 residents to officially jump the vaccine line, and CNN asks if covid line-jumping is ever OK.
NPR reports that social media content with covid misinformation is among the most highly engaged-with posts; meanwhile, Mississippi moves to correct "misleading" vaccine information found in official texts.
The FDA authorized a new manufacturer to help Johnson & Johnson with its vaccine production. Meanwhile, other contractors aiding Moderna and Pfizer's efforts are cashing in.
In other news, a study again shines a positive spotlight on remdesivir as a covid treatment; hospitals in Seattle and Colorado plan to treat children with covid-induced anosmia; and worries emerge about the pandemic's impact on STIs.
Meanwhile, New York Gov. Andrew Cuomo, a Democrat, is facing scrutiny for reportedly giving family members priority for covid testing last year.
Moncef Slaoui, who led Operation Warp Speed during the Trump administration, was fired from the Galvani Bioelectronics board of directors after it investigated and substantiated allegations of sexual harassment dating back several years.
Data on covid infections in migrant children detained in government shelters include 300 currently in the system. Elsewhere, figures show hospitalizations for older citizens are falling and Congress begins to plan what to do if a future pandemic strikes.
It was the first Senate confirmation -- by 52-48 with two Republicans joining all Democrats and Independents -- of an openly transgender official. Dr. Rachel Levine most recently served as Pennsylvania's secretary of health.
Following questions raised by U.S. safety board officials, AstraZeneca updated its clinical trial analysis -- finding its coronavirus vaccine to be 76% effective, rather than the 79% reported Monday. The report maintains that it is 100% effective at protecting against severe covid.
Today's early morning highlights from the major news organizations.
Opinion writers focus on these issues and more.
Read recent commentaries about drug-cost issues.
Elsewhere, Cuba is trying an experimental covid shot of its own, Paraguay struggles politically with offers to use China's vaccine and the E.U. plans to limit vaccine exports to other nations, echoing the U.S.' vaccine plan.
Editorial pages weigh in on covid and vaccines.
Read about the biggest pharmaceutical developments and pricing stories from the past week in KHN's Prescription Drug Watch roundup.
In other news, Texas will expand nursing home visits for covid-vaccinated residents; nearly half of U.S. public schools reportedly are open full time; and the World Happiness Report for 2021 seems surprisingly positive.
Other pharmaceutical news is on wearable drug-delivery systems, Boston Scientific, Fresenius Kabi Oncology and AbbVie.
It's been more than three months since the government’s last announcement of a large disbursement, the Wall Street Journal reports.
New research into "long covid" is throwing a spotlight on persistent symptoms of the disease, particularly neurological ones, amid worries that there is a serious prolonged problem to be tackled.
A new study says covid infections among people who've been vaccinated are possible but rare. Meanwhile the IBD drug infliximab is linked to lower covid antibody counts, and CNN explores the link between beards, masks and covid risks.
© 2026 KFF